- Home
- / AVITA Medical
AVITA Medical
Stock Price
$10.3
2024-10-29
Market Capitalization
$274.5 M
2024-10-29
Revenue
$64.3 M
FY, 2024
AVITA Medical Summary
Company Summary
- Overview
- AVITA Medical is a company focused on therapeutic acute wound care. It develops the RECELL system, a device that creates Spray-On Skin cells from a patient's skin to treat thermal burns and full-thickness skin defects. The company also offers Cohealyx, a collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix.
- Type
- Public
- Status
- Active
- Founded
- 2008
- HQ
- Santa Clarita, CA, US | view all locations
- Website
- https://avitamedical.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Jeremy Curnock Cook, Non-Executive Director
Suzanne Crowe, Non-Executive Director
LocationsView all
1 location detected
Santa Clarita, CA HQ
United States
28159 Avenue Stanford Suite 220, Valencia
AVITA Medical Financials
Summary Financials
- Revenue (FY, 2024)
- $64.3M
- Gross profit (FY, 2024)
- $55.2M
- Net income (FY, 2024)
- ($61.8M)
- Cash (FY, 2024)
- $14.1M
- EBIT (FY, 2024)
- ($56.6M)
- Enterprise value
- $303.6M